Bluejay Diagnostics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $125.00K.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $7.44M.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $2.79M.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.18M.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for fiscal 2024 was $7.44M, a 531.59% increase from fiscal 2023.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for fiscal 2023 was $1.18M.
- Bluejay Diagnostics, Inc. stock issued during period, value, new issues for fiscal 2021 was $18.86M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $125.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $7.44M 10-K · filed 2026-03-06 | |
| 2024-06-30 | $7.44M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $2.79M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.18M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.18M 10-Q · filed 2024-11-07 | |
| 2021-12-31 | $18.86M 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |